These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25887246)

  • 21. Metronidazole: utilization in the obstetric and gynecologic patient.
    Schwebke JR
    Sex Transm Dis; 1995; 22(6):370-6. PubMed ID: 8578410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis].
    Buitrón García Figueroa R; Gonzalo Butrón López F; Oropez Rechy G; Romero-Cabello R
    Ginecol Obstet Mex; 1997 Nov; 65():487-91. PubMed ID: 9441152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dealing with trichomoniasis.
    Young F
    J Fam Health Care; 2006; 16(5):153-5. PubMed ID: 17139977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of oral metronidazole in pregnancy. Risks, benefits, and practice guidelines.
    Murphy PA; Jones E
    J Nurse Midwifery; 1994; 39(4):214-20. PubMed ID: 7965190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis.
    Simbar M; Azarbad Z; Mojab F; Majd HA
    Phytomedicine; 2008 Dec; 15(12):1025-31. PubMed ID: 18824338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
    Nyirjesy P; Schwebke JR
    Future Microbiol; 2018 Apr; 13():507-524. PubMed ID: 29327947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Klion suspension in paediatry and gynaecology.
    Takács G
    Ther Hung; 1992; 40(4):189-91. PubMed ID: 1345028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis.
    Reichman O; Akins R; Sobel JD
    Sex Transm Dis; 2009 Nov; 36(11):732-4. PubMed ID: 19704395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience of successful treatment of patients with metronidazole-resistant Trichomonas vaginalis with zinc sulfate: A case series.
    Byun JM; Jeong DH; Kim YN; Lee KB; Sung MS; Kim KT
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):617-20. PubMed ID: 26522122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of sexually transmitted vaginosis/vaginitis.
    Lossick JG
    Rev Infect Dis; 1990; 12 Suppl 6():S665-81. PubMed ID: 2201078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of body mass index on therapeutic response to bacterial vaginosis in pregnancy.
    Mastrobattista JM; Klebanoff MA; Carey JC; Hauth JC; Macpherson CA; Ernest J; Cotroneo M; Leveno KJ; Wapner R; Varner M; Iams JD; Moawad A; Sibai BM; Miodovnik M; Dombrowski M; O'Sullivan MJ; Vandorsten JP; Langer O;
    Am J Perinatol; 2008 Apr; 25(4):233-7. PubMed ID: 18548397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of vaginitis.
    Egan ME; Lipsky MS
    Am Fam Physician; 2000 Sep; 62(5):1095-104. PubMed ID: 10997533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
    Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
    Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association Between Human Immunodeficiency Virus and Bacterial Vaginosis and Metronidazole Treatment Failure for Trichomonas vaginalis.
    Frechtling D; Chopra S; Ratnayake A; Kissinger PJ
    Sex Transm Dis; 2024 Jan; 51(1):61-64. PubMed ID: 37921835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vaginal suppository on bacterial vaginitis based on Persian medicine (Iranian traditional medicine): a randomised double blind clinical study.
    Baery N; Ghasemi Nejad A; Amin M; Mahroozade S; Mokaberinejad R; Bioos S; Anushiravani M; Aliasl J; Karimi Darmiyan M; Amin G
    J Obstet Gynaecol; 2018 Nov; 38(8):1110-1114. PubMed ID: 30084707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.
    Simoes JA; Bahamondes LG; Camargo RP; Alves VM; Zaneveld LJ; Waller DP; Schwartz J; Callahan MM; Mauck CK
    Br J Clin Pharmacol; 2006 Feb; 61(2):211-7. PubMed ID: 16433875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trichomoniasis in women. A personal method of treatment].
    Senra A
    Hospital (Rio J); 1969 Jul; 76(1):245-83. PubMed ID: 5307530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.